Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • NAT10-Driven ac4C RNA Modification Regulates Mouse Oocyte Ma

    2026-07-02

    NAT10-Mediated N4-Acetylcytidine Modification and Post-Transcriptional Regulation in Mouse Oocyte Maturation

    Study Background and Research Question

    Oocyte maturation is a pivotal step in mammalian reproduction, transitioning the oocyte to a state competent for fertilization and early embryogenesis. This process, especially in mice and humans, is characterized by an extended arrest at the germinal vesicle (GV) stage, during which transcription is largely silenced and maternal mRNA pools are established. The orchestration of oocyte maturation thus relies heavily on post-transcriptional regulation, including mRNA stability and translational control. Recent years have seen a surge of interest in epigenetic modifications of RNA—over 170 distinct types have been identified—owing to their influence on gene expression at the post-transcriptional level (reference study). However, the involvement of specific RNA modifications, such as N4-acetylcytidine (ac4C), and their regulatory enzymes in oocyte maturation remained largely unexplored until this work.

    Key Innovation from the Reference Study

    The study by Xiang et al. (2021) provides the first comprehensive analysis of ac4C modification dynamics and its functional significance during mouse oocyte maturation in vitro. Notably, the work identifies N-acetyltransferase 10 (NAT10) as the sole known mammalian enzyme responsible for ac4C deposition on mRNA in this context. By systematically linking NAT10 expression, ac4C levels, and oocyte developmental outcomes, the authors establish a direct mechanistic link between this epigenetic mark and successful progression through meiotic maturation.

    Methods and Experimental Design Insights

    • Expression Profiling: NAT10 mRNA and protein levels, as well as global ac4C content, were quantified in oocytes at different maturation stages using immunostaining and RNA analysis.
    • Functional Disruption: Small interfering RNA (siRNA)-mediated knockdown of NAT10 was performed in GV-stage oocytes, allowing assessment of downstream effects on ac4C abundance and meiotic progression.
    • Phenotypic Analysis: The rates of germinal vesicle breakdown (GVBD) and first polar body extrusion were measured as key indicators of meiotic progression and maturation quality.
    • Transcriptomic and RNA-Protein Interaction Mapping: RNA immunoprecipitation followed by high-throughput sequencing (RIP-seq) was conducted in HEK293T cells to identify ac4C-associated mRNAs and potential binding proteins. Bioinformatic approaches were used to predict ac4C readers, followed by RNA pulldown assays to validate interactions.

    Protocol Parameters

    • siRNA Transfection for NAT10 Knockdown: Microinjection of NAT10 siRNA into GV-stage mouse oocytes; culture in vitro for maturation assessment.
    • Oocyte Maturation Culture: Standard in vitro maturation (IVM) conditions, with hormone induction, typically for 16–18 hours to assess progression to metaphase II (MII).
    • ac4C Detection: Immunofluorescence staining of ac4C in oocyte cytoplasm and quantification by fluorescence intensity analysis.
    • RNA Immunoprecipitation (RIP-seq): Use of anti-ac4C antibodies to enrich for ac4C-modified RNAs from cell lysates, followed by sequencing and bioinformatic pathway analysis.
    • RNA Pulldown Assays: Biotin-labeled RNA probes containing ac4C modification were incubated with HEK293T lysates to identify interacting proteins by mass spectrometry.

    Core Findings and Why They Matter

    The central discovery is that both NAT10 expression and ac4C modification levels decrease as mouse oocytes transition from GV to MII stages (Xiang et al., 2021). Critically, siRNA-mediated knockdown of NAT10 led to a marked reduction in ac4C and significantly impaired meiotic maturation—as measured by a drop in first polar body extrusion rate from ~74.6% in controls to 34.6% in knockdown oocytes (p < 0.001). The rate of GVBD, however, was not significantly affected, indicating that NAT10-ac4C axis specifically influences the later stages of maturation.

    Transcriptomic analysis of ac4C-modified RNAs revealed enrichment in genes involved in nucleosome assembly, chromatin silencing, chromatin modification, and cytoskeletal anchoring—suggesting that ac4C may stabilize or enhance translation of transcripts essential for these processes.

    Finally, TBL3 was identified as a candidate ac4C-binding protein, potentially mediating downstream regulatory effects. This is a significant step toward deciphering the molecular machinery that reads ac4C marks in mammalian cells, since no ac4C "reader" proteins had previously been described in this context.

    Comparison with Existing Internal Articles

    The functional implications of ac4C modifications explored in this study align with a broader interest in RNA modification and post-transcriptional gene regulation in reproductive and translational research. For example, the internal analysis of the HyperScribe T7 High Yield RNA Synthesis Kit emphasizes how advanced in vitro transcription platforms can facilitate the study of RNA modifications, including capped and biotinylated RNA synthesis. Such technologies enable researchers to generate high-purity, modification-compatible RNA for dissecting functional consequences in oocyte systems or other cell models.

    Similarly, the article Translational RNA Synthesis: Mechanistic Precision and Strategy discusses how precision RNA synthesis tools like HyperScribe™ T7 empower translational scientists to interrogate RNA structure-function relationships, which could be directly applied to the study of ac4C-dependent regulatory mechanisms uncovered by Xiang et al.

    Limitations and Transferability

    While this study provides compelling evidence for the functional role of NAT10-mediated ac4C in mouse oocyte maturation, several limitations remain. First, the mechanistic link between specific ac4C-modified transcripts and their phenotypic effects in oocyte development requires further clarification. The use of HEK293T cells for transcriptomic and protein-interaction mapping, rather than primary oocytes, may limit direct transferability to the in vivo oocyte context. Additionally, the identification of TBL3 as an ac4C reader is preliminary, and its precise functional role in oocyte biology or ac4C recognition awaits further validation. Finally, although the work establishes the importance of ac4C in vitro, its relevance in human oocyte maturation and clinical assisted reproduction protocols remains to be demonstrated.

    Research Support Resources

    To facilitate investigations into RNA modifications such as ac4C, researchers require robust in vitro transcription platforms capable of generating large quantities of high-quality, structurally diverse RNA. The HyperScribe™ T7 High Yield RNA Synthesis Kit (SKU K1047) offers a flexible solution for T7 RNA polymerase transcription, supporting synthesis of capped, biotinylated, and dye-labeled RNAs, as well as transcripts incorporating modified nucleotides. Such features are valuable for RNA structure-function studies, probe generation, and assay development in epitranscriptomic research, including applications in RNA vaccine research or RNA interference experiments. For further workflow and troubleshooting guidance, see the comparative analysis in HyperScribe T7 High Yield RNA Synthesis Kit: Advanced Workflows. Researchers can leverage these resources to systematically investigate the functional impact of RNA modifications like ac4C in diverse biological systems.